Two Sigma Advisers’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.3M | Sell |
860,400
-76,800
| -8% | -$2.79M | 0.06% | 255 |
|
|
2025
Q1 | $33.9M | Buy |
937,200
+23,700
| +3% | +$858K | 0.08% | 235 |
|
|
2024
Q4 | $38.4M | Sell |
913,500
-74,300
| -8% | -$3.13M | 0.09% | 201 |
|
|
2024
Q3 | $54.9M | Buy |
987,800
+545,600
| +123% | +$30.3M | 0.13% | 146 |
|
|
2024
Q2 | $18.2M | Sell |
442,200
-6,000
| -1% | -$247K | 0.04% | 364 |
|
|
2024
Q1 | $20.9M | Buy |
448,200
+259,300
| +137% | +$12.1M | 0.05% | 334 |
|
|
2023
Q4 | $9.03M | Sell |
188,900
-40,600
| -18% | -$1.94M | 0.02% | 569 |
|
|
2023
Q3 | $8.18M | Sell |
229,500
-261,000
| -53% | -$9.3M | 0.02% | 536 |
|
|
2023
Q2 | $22.6M | Sell |
490,500
-7,400
| -1% | -$341K | 0.06% | 282 |
|
|
2023
Q1 | $20M | Buy |
497,900
+37,200
| +8% | +$1.49M | 0.05% | 333 |
|
|
2022
Q4 | $21.3M | Buy |
460,700
+409,300
| +796% | +$19M | 0.06% | 317 |
|
|
2022
Q3 | $2.13M | Buy |
+51,400
| New | +$2.13M | 0.01% | 1140 |
|
|
2021
Q4 | – | Sell |
-69,400
| Closed | -$6.26M | – | 2772 |
|
|
2021
Q3 | $6.26M | Sell |
69,400
-68,500
| -50% | -$6.18M | 0.02% | 692 |
|
|
2021
Q2 | $13.1M | Buy |
137,900
+5,800
| +4% | +$553K | 0.03% | 458 |
|
|
2021
Q1 | $15M | Buy |
132,100
+72,400
| +121% | +$8.24M | 0.04% | 432 |
|
|
2020
Q4 | $8.26M | Buy |
59,700
+22,300
| +60% | +$3.09M | 0.02% | 640 |
|
|
2020
Q3 | $3.07M | Sell |
37,400
-1,900
| -5% | -$156K | 0.01% | 949 |
|
|
2020
Q2 | $3.07M | Buy |
+39,300
| New | +$3.07M | 0.01% | 999 |
|
|
2016
Q1 | – | Sell |
-91,586
| Closed | -$10.3M | – | 2118 |
|
|
2015
Q4 | $10.3M | Sell |
91,586
-66,814
| -42% | -$7.5M | 0.06% | 313 |
|
|
2015
Q3 | $15.4M | Buy |
158,400
+104,000
| +191% | +$10.1M | 0.1% | 246 |
|
|
2015
Q2 | $5.57M | Buy |
54,400
+50,300
| +1,227% | +$5.15M | 0.04% | 444 |
|
|
2015
Q1 | $255K | Buy |
+4,100
| New | +$255K | ﹤0.01% | 1645 |
|
|
2014
Q4 | – | Sell |
-9,800
| Closed | -$555K | – | 2224 |
|
|
2014
Q3 | $555K | Buy |
+9,800
| New | +$555K | ﹤0.01% | 1160 |
|